Home>
US Stocks>
Ani Pharmaceuticals Inc

Ani Pharmaceuticals Inc share price today

(ANIP)

Ani Pharmaceuticals Inc share price is $56.8 & ₹4,810.11

$56.8

▲

-1.07

(-1.85%)

Market is closed - opens 8 PM, 04 Dec 2024

View live Ani Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Ani Pharmaceuticals Inc from India. Also see the sentimental analysis on Indian investors investing in Ani Pharmaceuticals Inc. Get details on the Indian mutual funds that are investing in Ani Pharmaceuticals Inc. Get Analyst recommendations and forecasts along with all the Ani Pharmaceuticals Inc's financials.

Ani Pharmaceuticals Inc share price movements

$56.18
$58.11
$56.80
1.09%
Downside
Day's Volatility :3.31%
Upside
2.25%
$48.20
$70.81
$56.80
15.14%
Downside
52 Weeks Volatility :31.93%
Upside
19.79%

Ani Pharmaceuticals Inc Returns

Period	Ani Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-8.06%	-6.2%	0.0%
6 Months	-13.63%	1.7%	0.0%
1 Year	15.83%	11.6%	0.0%
3 Years	44.13%	12.9%	-18.1%

Ani Pharmaceuticals Inc Key Statistics

in dollars & INR

Market Capitalization	$1.2B
Revenue TTM	$555.5M
EBITDA	$82.1M
Earnings Per Share (EPS)	$-0.47
Profit Margin	-1.28%
Quarterly Earnings Growth YOY	13.82%
Return On Equity TTM	-1.6%

How to invest in Ani Pharmaceuticals Inc from India?

It is very easy for Indian residents to invest directly in Ani Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ani Pharmaceuticals Inc stock in both rupees (INR) and dollars (USD). Search for Ani Pharmaceuticals Inc or ANIP on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ani Pharmaceuticals Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ani Pharmaceuticals Inc shares which would translate to 0.015 fractional shares of Ani Pharmaceuticals Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Ani Pharmaceuticals Inc

107%

Period: Sep 4, 2024 to Dec 3, 2024. Change in 30 Days versus previous period

Search volume for Ani Pharmaceuticals Inc on INDmoney from India has grown in the last 30 days as on Dec 4, 2024. 107% more investors are searching Ani Pharmaceuticals Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Ani Pharmaceuticals Inc

BlackRock Inc
12.64%
Vanguard Group Inc
6.41%
Goldman Sachs Group Inc
3.41%
State Street Corp
3.35%
Dimensional Fund Advisors, Inc.
3.12%
Ranger Investment Management LP
2.81%

Analyst Recommendation on Ani Pharmaceuticals Inc

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Ani Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Ani Pharmaceuticals Inc

What analysts predicted

Upside of 38.03%

Current:

$56.80

Target:

$78.40

Insights on Ani Pharmaceuticals Inc

Increasing Revenue
Revenue is up for the last 4 quarters, 131.65M → 148.33M (in $), with an average increase of 3.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 18.20M → -24.16M (in $), with an average decrease of 534.6% per quarter
Vs CTLT
In the last 1 year, Catalent, Inc. has given 53.0% return, outperforming this stock by 38.6%

Ani Pharmaceuticals Inc Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$201.6M	↑ 13.99%
Net Income	$15.5M	↓ 1539.96%
Net Profit Margin	7.69%	↑ 8.3%

	FY19	Y/Y Change
Revenue	$206.5M	↑ 2.47%
Net Income	$6.1M	↓ 60.67%
Net Profit Margin	2.95%	↓ 4.74%

	FY20	Y/Y Change
Revenue	$208.5M	↑ 0.93%
Net Income	$-22.5M	↓ 470.0%
Net Profit Margin	-10.82%	↓ 13.77%

	FY21	Y/Y Change
Revenue	$216.1M	↑ 3.67%
Net Income	$-42.6M	↑ 88.94%
Net Profit Margin	-19.71%	↓ 8.89%

	FY22	Y/Y Change
Revenue	$316.4M	↑ 46.38%
Net Income	$-47.9M	↑ 12.42%
Net Profit Margin	-15.14%	↑ 4.57%

	FY23	Y/Y Change
Revenue	$486.8M	↑ 53.87%
Net Income	$18.8M	↓ 139.21%
Net Profit Margin	3.86%	↑ 19.0%

	Q2 FY23	Q/Q Change
Revenue	$116.5M	↑ 9.14%
Net Income	$6.2M	↑ 333.98%
Net Profit Margin	5.36%	↑ 4.01%

	Q3 FY23	Q/Q Change
Revenue	$131.8M	↑ 13.11%
Net Income	$9.9M	↑ 59.17%
Net Profit Margin	7.54%	↑ 2.18%

	Q4 FY23	Q/Q Change
Revenue	$131.7M	↓ 0.13%
Net Income	$1.2M	↓ 88.38%
Net Profit Margin	0.88%	↓ 6.66%

	Q1 FY24	Q/Q Change
Revenue	$137.4M	↑ 4.39%
Net Income	$18.2M	↑ 1476.36%
Net Profit Margin	13.25%	↑ 12.37%

	Q2 FY24	Q/Q Change
Revenue	$138.0M	↑ 0.44%
Net Income	$-2.3M	↓ 112.56%
Net Profit Margin	-1.66%	↓ 14.91%

	Q3 FY24	Q/Q Change
Revenue	$148.3M	↑ 7.46%
Net Income	$-24.2M	↑ 956.67%
Net Profit Margin	-16.29%	↓ 14.63%

	FY18	Y/Y Change
Total Assets	$430.6M	↑ 4.48%
Total Liabilities	$233.3M	↓ 1.7%

	FY19	Y/Y Change
Total Assets	$456.8M	↑ 6.08%
Total Liabilities	$244.0M	↑ 4.57%

	FY20	Y/Y Change
Total Assets	$461.2M	↑ 0.96%
Total Liabilities	$265.5M	↑ 8.81%

	FY21	Y/Y Change
Total Assets	$771.6M	↑ 67.31%
Total Liabilities	$412.9M	↑ 55.51%

	FY22	Y/Y Change
Total Assets	$760.1M	↓ 1.49%
Total Liabilities	$421.5M	↑ 2.1%

	FY23	Y/Y Change
Total Assets	$904.4M	↑ 18.99%
Total Liabilities	$446.8M	↑ 6.0%

	Q2 FY23	Q/Q Change
Total Assets	$859.3M	↑ 12.3%
Total Liabilities	$424.9M	↓ 0.21%

	Q3 FY23	Q/Q Change
Total Assets	$889.9M	↑ 3.56%
Total Liabilities	$435.2M	↑ 2.43%

	Q4 FY23	Q/Q Change
Total Assets	$904.4M	↑ 1.63%
Total Liabilities	$471.7M	↑ 8.38%

	Q1 FY24	Q/Q Change
Total Assets	$914.5M	↑ 1.12%
Total Liabilities	$462.6M	↓ 1.93%

	Q2 FY24	Q/Q Change
Total Assets	$920.8M	↑ 0.68%
Total Liabilities	$465.0M	↑ 0.53%

	Q3 FY24	Q/Q Change
Total Assets	$1.3B	↑ 39.82%
Total Liabilities	$856.6M	↑ 84.21%

	FY18	Y/Y Change
Operating Cash Flow	$67.1M	↑ 70.16%
Investing Cash Flow	$-27.4M	↓ 74.65%
Financing Cash Flow	$-27.8M	↓ 138.44%

	FY19	Y/Y Change
Operating Cash Flow	$45.6M	↓ 31.97%
Investing Cash Flow	$-27.5M	↑ 0.62%
Financing Cash Flow	$1.3M	↓ 104.49%

	FY20	Y/Y Change
Operating Cash Flow	$15.3M	↓ 66.54%
Investing Cash Flow	$-68.3M	↑ 148.0%
Financing Cash Flow	$-1.4M	↓ 215.12%

	FY21	Y/Y Change
Operating Cash Flow	$3.3M	↓ 78.24%
Investing Cash Flow	$-105.5M	↑ 54.39%
Financing Cash Flow	$194.6M	↓ 13622.93%

	FY22	Y/Y Change
Operating Cash Flow	$-31.2M	↓ 1039.28%
Investing Cash Flow	$-15.7M	↓ 85.08%
Financing Cash Flow	$-5.1M	↓ 102.63%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$20.6M	↓ 3.72%
Investing Cash Flow	$-6.8M	↑ 190.1%
Financing Cash Flow	$80.2M	↓ 1862.31%

Ani Pharmaceuticals Inc Technicals Summary

Sell

Neutral

Buy

Ani Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Ani Pharmaceuticals Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Ani Pharmaceuticals Inc	3.32%	-13.63%	15.83%	44.13%	-2.59%
Neurocrine Biosciences Inc.	4.45%	-5.83%	6.2%	56.02%	7.77%
Haleon Plc Spon Ads	-0.92%	13.23%	18.07%	30.5%	30.5%
Zoetis Inc.	0.93%	0.56%	-1.58%	-20.7%	45.26%
Viatris Inc.	15.28%	25.83%	37.36%	6.11%	-19.22%
Catalent, Inc.	4.67%	10.74%	57.88%	-49.17%	18.02%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Ani Pharmaceuticals Inc	49.06	NA	1.06	-0.26	-0.02	0.01	NA	20.74
Neurocrine Biosciences Inc.	33.8	33.8	0.3	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	28.41	28.41	1.72	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	32.88	32.88	2.44	5.87	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.08	2.67	-0.04	0.02	0.04	16.58
Catalent, Inc.	211.02	NA	509.25	0.2	-0.11	0.0	NA	19.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Ani Pharmaceuticals Inc	Buy	$1.2B	-2.59%	49.06	-1.28%
Neurocrine Biosciences Inc.	Buy	$12.8B	7.77%	33.8	17.21%
Haleon Plc Spon Ads	Buy	$43.7B	30.5%	28.41	10.75%
Zoetis Inc.	Buy	$79.7B	45.26%	32.88	26.55%
Viatris Inc.	Hold	$15.1B	-19.22%	224.4	-5.87%
Catalent, Inc.	Hold	$11.1B	18.02%	211.02	-9.34%

About Ani Pharmaceuticals Inc

ani pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. we focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. our two pharmaceutical manufacturing facilities located in baudette, minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize cortrophin gel and cortrophin-zinc.

Organization	Ani Pharmaceuticals Inc
Employees	642
CEO	Mr. Nikhil Lalwani
Industry	Health Technology

Important FAQs about investing in Ani Pharmaceuticals Inc from India :

What is Ani Pharmaceuticals Inc share price today?

Ani Pharmaceuticals Inc (ANIP) share price today is $56.80.

Can Indians buy Ani Pharmaceuticals Inc shares?

Yes, Indians can invest in the Ani Pharmaceuticals Inc (ANIP) from India.

With INDmoney, you can buy Ani Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Ani Pharmaceuticals Inc at zero transaction cost.

How can I buy Ani Pharmaceuticals Inc shares from India?

It is very easy to buy Ani Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ani Pharmaceuticals Inc be purchased?

Yes, you can buy fractional shares of Ani Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Ani Pharmaceuticals Inc stocks?

To start investing in Ani Pharmaceuticals Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.